Company
Chairman, CEO, Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
Organization not stated
Chairman
Source not stated
Organization not stated
CEO
Proxy statement
Organization not stated
Board Member
Proxy statement
Recorded roles and earnings-call appearances connecting this person to public companies.
Company
Chairman, CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Centessa Pharmaceuticals plc (CNTA) | Chief Financial Officer | $534,625 | $3,842,835 |
| 2024 | Centessa Pharmaceuticals plc (CNTA) | Chief Financial Officer | $295,313 | $4,120,748 |
| 2023 | Centessa Pharmaceuticals plc (CNTA) | Chief Financial Officer | — | — |
Earnings-call appearances and filed executive appointments or departures, newest first.
AMICUS THERAPEUTICS, INC. Q1 FY2022 Earnings Call
AMICUS THERAPEUTICS, INC. Q4 FY2021 Earnings Call
AMICUS THERAPEUTICS, INC. Q3 FY2021 Earnings Call
AMICUS THERAPEUTICS, INC. Q2 FY2021 Earnings Call
AMICUS THERAPEUTICS, INC. Q4 FY2020 Earnings Call
AMICUS THERAPEUTICS, INC. Q3 FY2020 Earnings Call
AMICUS THERAPEUTICS, INC. Q1 FY2020 Earnings Call